FDA Panel Supports MS Drug''s Market Return
Wed, 08 Mar 2006 09:12 PM EST
... FDA Panel Unanimously Supports MS Drug Tysabri''s Return to U.S. Market ...
Related Topics
- Multiple Sclerosis
- Liver Panel
- Tysabri
- Drug Safety
- Morphine ER
- Research
- Mammography
- Rofecoxib
- Rofecoxib Oral Suspension
- Prescription Drugs
- Multiple Sclerosis/ms
- Cerivastatin - Withdrawn From The Market
- Drug Side Effects
- Docusate
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Tragacanth
- Tacrolimus ointment

Not Signed In -


